MGMT and central nervous system cancer: While some studies have suggested ATRA can sensitize glioma cells to chemotherapy or radiation [22,23], the specific concurrent downregulation of MGMT mRNA alongside key stemness markers in GBM cells cultured under neurosphere conditions, as observed here, adds to the understanding of ATRA’s potential multifaceted impact.